Oasmia Pharmaceutical

Russia
Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia, 752 28

Company profile

Oasmia Pharmaceutical company profile

Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.

Business identity

Contact email
[email protected]
Phone number
+46 18 50 54 40
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
1990-01-01, Year

Headquarters

Postal code
752 28
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$37M
Last funding
Post IPO Equity / $17.7M / 2019-03-05
Last equity funding
Post IPO Equity / $17.7M
Investors
1
Lead investors
1
Founders
1
Articles
17
Exited on
2010-06-24

Founders and investors

Founders

Julian Aleksov

Lead investors

Yorkville Advisors

Investors

Yorkville Advisors